NASDAQ:ETON
Eton Pharmaceuticals Inc. Stock News
$3.62
-0.0800 (-2.16%)
At Close: May 30, 2024
Eton Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript
09:34am, Saturday, 11'th May 2024
Eton Pharmaceuticals, Inc. Q1 2024 Earnings Call Transcript May 9, 2024 4:30 PM ET Company Participants David Krempa - Chief Business Officer Sean Brynjelsen - Chief Executive Officer James Gruber - C
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
04:01pm, Thursday, 09'th May 2024
• Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13th straight quarter of sequential product sales growth• Acquired PKU GOLIKE®, launched Nitisinone, and subm
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
04:05pm, Wednesday, 01'st May 2024
DEER PARK, Ill., May 01, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases,
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
07:00am, Tuesday, 30'th Apr 2024
- Company anticipates 10-month review for potential approval in Q1 2025 -- Eton expects ET-400 and Alkindi Sprinkle® to achieve potential combined peak sales of more than $50 million annually -- Prod
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
04:30pm, Monday, 29'th Apr 2024
DEER PARK, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercial
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
02:00am, Friday, 22'nd Mar 2024
DEER PARK, Ill., March 22, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercia
Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript
09:38pm, Thursday, 14'th Mar 2024
Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates
06:16pm, Thursday, 14'th Mar 2024
Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.04 per share a year ago.
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
04:01pm, Thursday, 14'th Mar 2024
DEER PARK, Ill., March 14, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercia
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
04:01pm, Thursday, 29'th Feb 2024
DEER PARK, Ill., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commerciali
Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
06:50am, Wednesday, 21'st Feb 2024
DEER PARK, Ill., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing
Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
06:50am, Friday, 02'nd Feb 2024
-- Eton Cares patient support program offers $0 co-pay to eligible, commercially insured patients* ---- Current Nitisinone market is estimated to exceed $50 million annually ---- Product is now availa
5 Under-$15 Stocks Wall Street Analysts Recommend Buying
09:01am, Thursday, 14'th Dec 2023
After a stellar rally in Wall Street this year, investors with limited funds but desire to participate in the market can bet on low-priced top-ranked stocks like Eton Pharmaceuticals (ETON), LegalZoom
Eton Pharmaceuticals, Inc. (ETON) Q3 2023 Earnings Call Transcript
05:18pm, Thursday, 09'th Nov 2023
Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants David Krempa - Chief Business Officer Sean Brynjelsen - Chief Executive Offi
Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
04:01pm, Thursday, 09'th Nov 2023
DEER PARK, Ill., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercial